Prediction of the risk of developing a disseminated infection for patients admitted to an intensive care unit
US10466255B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | May 11, 2016 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | May 11, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for predicting the risk of developing a disseminated infection in a patient admitted to intensive care having no clinical symptoms of such infection includes: determining a first dose of gelsolin G1 in a biological sample from the patient originating from a first sample taken at time T1, carried out between the day of intensive care admission and 48 hours afterward; determining a second dose of gelsolin G2 in a biological sample from the patient originating from a second sample taken at time T2, carried out two to three days after the first sampling; calculating the variation between the dose of gelsolin G2 and the dose of gelsolin G1, giving a Δ value; and comparing the Δ value to a threshold value S determined beforehand from two patient populations admitted to intensive care, one not having developed a disseminated infection and the other having developed such an infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.